Endovascular Thrombectomy Alone Versus Intravenous Thrombolysis Plus Thrombectomy on Acute Basilar Artery Occlusion

Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorThe First Affiliated Hospital of University of Science and Technology of China

About this trial

To assess the effect of endovascular thrombectomy alone compared to intravenous thrombolysis plus endovascular thrombectomy in acute basilar artery occlusion patients within 4.5 hours from onset on efficacy and safety outcomes.

Eligibility criteria

Qualifiers

Patients presenting with posterior circulation ischemic stroke symptoms due to basilar artery occlusion or vertebral artery occlusions that prevent antegrade flow into the basilar artery;

Time from stroke onset to randomization within 4.5 hours of estimated time of basilar artery occlusion;

Patient's age ≥ 18 years;

Presence of basilar artery or vertebral artery occlusion, confirmed by CT Angiography (CTA), MR Angiography (MRA) or Digital Subtraction Angiography (DSA). In case of vertebral artery occlusion, the occlusion must completely prevent antegrade flow into the basilar artery;

Disqualifiers

CT or MR evidence of intracerebral hemorrhage (the presence of < 10 microbleeds is allowed);

Pre-stroke modified Rankin scale (mRS) score ≥ 2;

Posterior circulation Acute Stroke Prognosis Early CT Score (PC-ASPECTS) on CT/ CTA-Source Images<6; PC-ASPECTS on magnetic resonance imaging-diffusion weighted imaging (MRI-DWI) <5;

Pregnant or lactating women;

Trial design

Treatments tested in this trial

  • Intravenous thrombolysis
  • Endovascular thrombectomy

Treatment groups

338 Participants
are divided into 2 treatment groups